πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7067633

Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in

The Board of Regents of the University of Texas System Β· Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7067256

Ribozyme mediated inactivation of the androgen receptor

The Board of Regents of the University of Texas System Β· Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7067109

Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7067254

Diagnosis and treatment of inflammation and hyperactive immune conditions

The Board of Regents of the University of Texas System Β· Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7063847

Compositions and methods for enhancing immune responses mediated by antigen-presenting cel

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7060689

Methods and compositions for delivery and retention of active agents to lymph nodes

The Board of Regents of the University of Texas System Β· Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7060466

Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene

The Board of Regents of the University of Oklahoma Β· Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7056509

Antibody methods for selectively inhibiting VEGF

The Board of Regents of the University of Texas System Β· Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7056897

Inducible expression vectors and methods of use thereof

THE ARIZONA BOARD OF REGENTS Β· Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7052829

Prevascularized constructs for implantation to provide blood perfusion

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7041784

Apoptotic compounds

The Board of Regents of the University of Texas System Β· Granted Tue May 09 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7037583

Functionalized zirconium oxide particles

The Board of Regents of the University of Texas System Β· Granted Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7033603

Drug releasing biodegradable fiber for delivery of therapeutics

The Board of Regents of the University of Texas Β· Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7033750

Recombinant P53 adenovirus methods and compositions

The Board of Regents of the University of Texas System Β· Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7029838

Prevascularized contructs for implantation to provide blood perfusion

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Apr 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7029696

Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II)

The Board of Regents of the University of Texas System Β· Granted Tue Apr 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7022484

Methods for treating neuropathological states and neurogenic inflammatory states and metho

The Board of Regents of the University of Texas System Β· Granted Tue Apr 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7022720

Synthetic diazonamides as novel anti-mitotic agents

The Board of Regents of the University of Texas System Β· Granted Tue Apr 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7022712

Solubilization of weak bases

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Apr 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7018987

Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Mar 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7008633

Local regional chemotherapy and radiotherapy using in situ hydrogel

The Board of Regents of the University of Texas System Β· Granted Tue Mar 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7005512

Methods and compositions for stabilizing microtubules and intermediate filaments in striat

The Board of Regents of the University of Texas System Β· Granted Tue Feb 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7005424

Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells

The Board of Regents of the University of Texas System Β· Granted Tue Feb 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7001718

Method of inhibiting pathogenicity of infectious agents

THE ARIZONA BOARD OF REGENTS Β· Granted Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired